|
Market Closed -
Nasdaq Stockholm
13:00:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.1866 SEK | -0.21% |
|
0.00% | -30.37% |
| 10-19 | Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device | MT |
| 10-19 | Acarix AB Receives Regulatory Approval In Saudi Arabia | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 23.37M | - | - | - | ||
| 249B | |||||
| 162B | |||||
| 157B | |||||
| 66.22B | |||||
| 52.3B |
- Stock Market
- Stocks
- ACARIX Stock
- Charts Acarix AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
